Previous studies have suggested an association between psoriasis and metabolic syndrome. In a recent systematic review and meta-analysis, researchers aimed to establish this potential relationship further.
...
Although psoriasis is associated with an increased risk of premature death, little is known about the factors that contribute to this risk. In a recent study, researchers aimed to assess the effects of...
To determine the safety and efficacy of tildrakizumab, researchers conducted 2 phrase 3 trials with over 1800 patients with moderate-to-severe plaque psoriasis.
In a recent study, researchers used data from the 2013 US National Health and Wellness Survey to assess the health-related quality of life and productivity among adults with atopic dermatitis and psoriasis...
After clinical trials demonstrated its efficacy, the US Food and Drug Administration approved a biologic therapy for the treatment of patients with moderate to severe plaque psoriasis.
